Verva’s scientists will be providing scientific presentations from the Verva Research and Development programs at the following international conferences:
44th Annual Meeting of the European Association for the Study of Diabetes
Rome 7 - 11 September 2008
- Use of Gene Expression Signature technology to identify VVP808, a novel insulin sensitiser with efficacy in vitro and in vivo
K. Walder, J. Molero, N. Konstantopoulos, D. Segal, V. Foletta, K. Windmill, J. Curran, T. Dyer, K. Shields, J. Jowett, G. Krippner, J. Blangero, G. Collier
- Use of a GLUT4 translocation assay strategy to identify new insulin sensitisers with efficacy in vitro and in vivo
Juan C. Molero, Nicky Konstantopoulos, Cordula Hohnen-Behrens, Jiming Ye, David Segal, Gregory Collier, Ken Walder and David E. James
2008 Australian Diabetes Society/Australian Diabetes Educators Association Annual Scientific Meeting
28-30 August 2008 Melbourne
- Transcription-based Identification of Insulin Resistance Subtypes
N. Konstantopoulos, J. Jowett, V. Foletta, C. Swinton, T. Connor, A. Sanigorski, S. Morrison, S. Jones, R. Fahey, D. Segal, J. Blangero and K. Walder
- VVP808 is a novel agent that improves glucose tolerance in DIO mice
B. Spolding, T. Connor, M. DeVries, S. Wanyonyi, A. Cooper, S. Lee, J.C. Molero, K. Walder